ArticleTrauma surgery & acute care open2025
High-grade liver injury: outcomes with a trauma surgery-liver surgery collaborative approach.
Article in Trauma surgery & acute care open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Delayed hemorrhage from a variant renal-origin inferior phrenic artery after liver trauma repair: A case report.Trauma case reports · 2026Article
- Contemporary management pathways in liver trauma: predominant and successful use of non-operative strategies at a high-volume tertiary center.Langenbeck's archives of surgery · 2026Article
- Comparison of American Association for the Surgery of Trauma (AAST) and Japanese Association for the Surgery of Trauma (JAST) classification systems for predicting mortality in surgically managed liver trauma: A single-center experience.Fukushima journal of medical science · 2026Observational
- Major liver necrosis after blunt trauma.Trauma surgery & acute care open · 2026Article
- Selective non-operative management of traumatic liver injury in Palestine: a retrospective single-center cohort study.Frontiers in medicine · 2026Article
- Article
- Advancing care in high-grade liver injuries: the transformative impact of multidisciplinary collaboration.Trauma surgery & acute care open · 2025Article
Corrections and comments
- Commented on by
Authors and funding
24 authors.
Funding
Abstract
Background: Operative mortality for high-grade liver injury (HGLI) remains 42% to 66%, with near-universal mortality after retrohepatic caval injury. The objective of this study was to evaluate mortality and complications of operative and nonoperative management (OM and NOM) of HGLI at our institution, characterized by a trauma surgery-liver surgery collaborative approach to trauma care. Methods: This was an observational cohort study of adult patients (age ≥16) with HGLI (The American Association for Surgery of Trauma (AAST) grades IV and V) admitted to an urban level I trauma center from January 2010 to November 2021. Data were obtained from the electronic medical record and state trauma registry. Patients were categorized by management strategy: immediate OM or planned NOM. The primary outcome was 30-day mortality. Results: Our institution treated 179 patients with HGLI (78% blunt, 22% penetrating); 122 grade IV (68%) and 57 grade V (32%) injuries. All abdominal gunshot wounds and 49% of blunt injuries underwent initial OM; 51% of blunt injuries were managed initially by NOM. Procedures at the initial operation included hepatorrhaphy±packing (66.4%), nonanatomic resection (5.6%), segmentectomy (9.3%), and hepatic lobectomy (7.5%). Thirty-day mortality in the OM group was substantially lower than prior reports (23.4%). Operative mortality attributable to the liver injury was 15.7%. 19.4% of patients failed NOM with one death (1.4%). Conclusion: We report an operative mortality of 23.4% for HGLI in a trauma care system characterized by a collaborative approach by trauma surgeons and liver surgeons. Level of evidence: III.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.